{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380004232158973697.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Kei Zaitsu"}],"foaf:familyName":[{"@value":"Zaitsu"}],"foaf:givenName":[{"@value":"Kei"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360004232158973696","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1016/j.forsciint.2015.02.004"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0379073815000584?httpAccept=text/plain"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0379073815000584?httpAccept=text/xml"},{"@type":"PMID","@value":"25703013"}],"notation":[{"@value":"Metabolism of the designer drug α-pyrrolidinobutiophenone (α-PBP) in humans: Identification and quantification of the phase I metabolites in urine"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.forsciint.2015.02.004_GCuQSN7JGEoxjy9Z71bumINa50X"},{"@type":"OPENAIRE","@value":"doi_dedup___::7247333d71535fcf4f4754a64a8749c4_GCuQSN7JGEoxjy9Z71bumINa50X"}]}